We are live on
!
Find out more
ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
595 hedge funds and large institutions have $30B invested in Alexion Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 218 increasing their positions, 214 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
96% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 45
27% more call options, than puts
Call options by funds: $551M | Put options by funds: $435M
15% more capital invested
Capital invested by funds: $26B → $30B (+$4.01B)
6% more funds holding
Funds holding: 559 → 595 (+36)
2% more repeat investments, than reductions
Existing positions increased: 218 | Existing positions reduced: 214
0% more funds holding in top 10
Funds holding in top 10: 19 → 19 (0)
Holders
595
Holders Change
+36
Holders Change %
+6.44%
% of All Funds
14.83%
Holding in Top 10
19
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.47%
New
88
Increased
218
Reduced
214
Closed
45
Calls
$551M
Puts
$435M
Net Calls
+$117M
Net Calls Change
-$98.3M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$636M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$118M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$83.6M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$69.1M |
| 5 |
Alkeon Capital Management
New York
|
+$67.9M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$328M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
-$213M |
| 3 |
Goldman Sachs
New York
|
-$183M |
| 4 |
State Street
Boston,
Massachusetts
|
-$82.3M |
| 5 |
BlackRock
New York
|
-$77.3M |
